Our findings reveal a significant association, with elevated EAAT3 levels prevalent in 47 out of 54 NSCLC samples, coinciding with increased expressions of RELA and the NF-κB signaling target gene, BAX (Fig. 6A–C). This evidence concerns the gene SLC1A1 and non-small cell lung carcinoma.